- Investing Ideas
- /
- U.K. Pharmaceuticals & Biotech High Insider Buying
U.K. Pharmaceuticals & Biotech High Insider Buying
Results
11
Stocks with high levels of insider buying the past 3 months and good analyst coverage.
11 companies
GSK
Market Cap: UK£54.6b
Engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.
GSK
UK£13.37
7D
4.8%
1Y
-15.6%
Indivior
Market Cap: UK£850.9m
Develops, manufactures, and sells buprenorphine-based prescription drugs for the treatment of opioid dependence and related disorders in the United States, Europe, Canada, Australia, and internationally.
INDV
UK£6.89
7D
-0.4%
1Y
-54.8%
4basebio
Market Cap: UK£144.1m
Engages in the research, development, manufacturing, and commercialization of synthetic DNA and RNA products, and targeted non-viral vector solutions in the United States, Europe, and internationally.
4BB
UK£11.25
7D
-2.2%
1Y
8.7%
Diaceutics
Market Cap: UK£102.3m
A diagnostic commercialisation company, provides data, data analytics, and implementation services for pharmaceutical companies worldwide.
DXRX
UK£1.21
7D
7.6%
1Y
17.5%
Sareum Holdings
Market Cap: UK£24.7m
A clinical stage small molecule drug development company, engages in the discovery and development of therapeutic drugs for cancer and autoimmune diseases.
SAR
UK£0.17
7D
0%
1Y
-34.6%
Shield Therapeutics
Market Cap: UK£20.7m
A commercial stage specialty pharmaceutical company, focuses on commercialization of pharmaceuticals to treat unmet medical needs.
STX
UK£0.024
7D
-16.1%
1Y
59.3%
Oxford BioDynamics
Market Cap: UK£8.8m
Operates as a biotechnology company that discovers and develops biomarkers for use in the pharmaceutical and biotechnology industry primarily in the United States and the United Kingdom.
OBD
UK£0.0045
7D
5.9%
1Y
-95.2%
Theracryf
Market Cap: UK£4.8m
A clinical stage therapeutics company, engages in the development of therapeutics for oncology and behavioral brain disorders.
TCF
UK£0.0022
7D
0%
1Y
-71.0%
Genflow Biosciences
Market Cap: UK£3.6m
Operates as a biotechnology company that focuses on developing biological interventions aimed at tackling the effects of ageing, slowing, and halting the ageing process, and reducing the incidence of age-related diseases with increase in health span in the United Kingdom and Belgium.
GENF
UK£0.01
7D
4.6%
1Y
-34.9%
Roquefort Therapeutics
Market Cap: UK£2.9m
A material biotech company, engages in the development of medicines for the treatment of cancer.
ROQ
UK£0.018
7D
2.8%
1Y
-61.1%
AIM ImmunoTech
Market Cap: US$2.0m
An immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States.
0A4Y
US$0.028
7D
3.7%
1Y
-94.3%